Where does Rapid Pathogen Screening, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rapid Pathogen Screening, Inc. ranks #14,888 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rapid Pathogen Screening, Inc. hold?

Rapid Pathogen Screening, Inc. holds 20 US utility patents granted between 2015 and 2024, spanning 11 technology areas.

What is Rapid Pathogen Screening, Inc.'s Innovation Score?

Rapid Pathogen Screening, Inc. has an Innovation Score of 34.8 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Rapid Pathogen Screening, Inc. focus on?

Rapid Pathogen Screening, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 16 patents, ranking #956 of 7,863 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Rapid Pathogen Screening, Inc.'s patent grant rate increasing or decreasing?

Rapid Pathogen Screening, Inc.'s recent grant velocity is -82% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Rapid Pathogen Screening, Inc.'s patents?

Rapid Pathogen Screening, Inc.'s patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rapid Pathogen Screening, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Rapid Pathogen Screening, Inc.

USPTO PatentsView assignee record - 20 granted patents across 11 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rapid ranks #14,888 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 11 technology areas.

#14,888
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (34.8/100): 18.8
avg claims per patent: -82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14888 · US Corporation #14,888 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,888/49,997
PHOTO-FINISH Quick Quack Car…
CPC-FOCUS G01N · 11 areas
INNOV-THIN 34.8/100
CLAIMS-RICH 18.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -82% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Quick Quack Car Wash Holdings, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rapid’s 34.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (30%) Velocity 1.3 pts (4%) Breadth 11.7 pts (34%) Claim depth 11.3 pts (32%)

Qualcomm Incorporated · highest

85
Rapid Pathogen… · this assignee

35
3D Lighting… · lowest

7

What this shows Rapid's Innovation Score is 34.8/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rapid?

Each dot is one of Rapid’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rapid’s own 18.8 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Rapid vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rapid's grants concentrate

Rapid Pathogen Screening, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 80% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2015 (7 grants) versus a trough of 1 in 2020. By volume, Rapid sits between Quick Quack Car Wash Holdings, LLC and Roman Cement, LLC.

Rapid's three-year grant acceleration

Rapid Pathogen Screening, Inc. shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Quick Quack Car W…

20
Qure ai Private

20
R A Jones &

20
Railscales

20
Rcrdclub

20
RDP

20
Robel Bahnbaumasc…

20
Roman Cement

20
Rapid Pathogen Sc… ◀

20

What this shows Rapid holds 20 patents at rank #14,880, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rapid

By rank, the assignees closest to #14,880 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Rapid's primary technology class.

Rapid's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Rapid Pathogen Screening, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	35.0%
2016	2	10.0%
2017	2	10.0%
2018	3	15.0%
2019	3	15.0%
2020	1	5.0%
2021	1	5.0%
2024	1	5.0%

Which technologies does Rapid Pathogen Screening, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 16

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 6

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 6

Y10T - Technical Subjects Covered BY Former US Classification 6

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

C07K - Peptides 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rapid Pathogen Screening, Inc.'s patent record in context - here's where to go next.

Rapid Pathogen Screening, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 80% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #14,888 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rapid Pathogen Screening, Inc. against Quick Quack Car Wash Holdings, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.